Top Stories
- American starts letting customers mix cash and miles for tickets
- Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion
- Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
- BioMarin reports five-year Pompe disease data showing durable motor function
- How AI is redefining Wall Street jobs — and boosting demand for this new 'hottest skill' by 1,721%
